News About: Pharm. Industry
Will Hanmi reappear the success of its impotency drug, Palpal?Hanmi Pharm, which has recorded the success in the impotency treatment ‘Viagra’ generic market, has raised curiosity in the pharmaceutical industry if it would revive the succes...
|
GSK will launch the first tetravalent flu vaccine ‘Fluarix Tetra’
GSK announced that it would launch the first domestic tetravalent influenza vaccine ‘Fluarix Tetra’.
Fluatrix Tetra includes 2 types of virus type A (A/H1N1, A.H3N2) and 2 types of virus type B (B-Victoria, B-Yamagat...
KPMA and KRPIA get together to choose ethical management over injustice
On the 22nd, the Compliance Program Academy (hereinafter referring to CP Academy) will be jointly held by the Korea Pharmaceutical Manufacturers Association (KPMA) and the Korean Research-based Pharma Industry Associa...
Japanese pharmaceutical companies have shown significant growth with 9% increased outpatient prescriptionsJapanese pharmaceutical companies have made significant increases in the outpatient prescription market on the first quarter.
According to the Medipana News’s analysis result o...
|
Two different opinions over the new power ‘NOAC,’ “The New Weapon” vs. “Needs more researches”
Entering the domestic market, evaluation towards the new oral anti-coagulant (hereinafter referring to NOAC) has made a contrary. It is divided into doctors with high expectations on fewer side effects than the existi...
Domestic companies were divided into two groups over the strategy for Januvia generics
Last month, the product attracted the most interests of the industry after enforcement of the Patent Linkage System was the diabetes treatment ‘Januvia.’
In order to launch the product ahead of other in the annually ...
Multinational and domestic pharmaceutical companies are getting ready to compete in the KRW 100 billion COPD treatment market
The size of the entire COPD (Chronic Obstructive Pulmonary Disease) treatment market is estimated at approximately KRW 100 billion, and the two leading products are Seretide(GSK) and Spiriva(Boehringer Ingelheim). The...
Dong-A looks forward to achieving the top pharmaceutical company with its 4 new drugsThe Dong-A ST’s constant R&D investment and effort launched the 24th domestic new drug.
Dong-A ST (CEO and President Chan-il Park) announced on the 17th that its first FDA-appr...
|
The 3-way competition among DHL, FedEx and World Courier for the special medicine shipping
International express parcel companies, DHL and FedEx, have participated in the ‘Bio Korea’ conference, held from the 8th and 10th of April.
The two companies have focused on promoting the special medicine shipping a...
Why would many MRs with high sales retire recently?
“The medical representatives (MR), also known as specialists who have recently retired from their companies, are personnel with high sales. There are now more retirements than turnovers among MRs.”
The trend of job t...
